Literature DB >> 17229666

Low serum alkaline phosphatase activity and pathologic fracture: case report and brief review of hypophosphatasia diagnosed in adulthood.

Hasnain M Khandwala1, Steven Mumm, Michael P Whyte.   

Abstract

OBJECTIVE: To describe an elderly patient with low serum alkaline phosphatase (ALP) activity detected after a pathologic fracture and to characterize hypophosphatasia in adult patients.
METHODS: We present a case report of a 64-year-old woman, who was referred after sustaining an atraumatic femoral fracture treated successfully with intramedullary nailing. Clinical, biochemical, radiologic, and molecular studies explore the differential diagnosis of her hypophosphatasemia, and the features, diagnosis, and management of the adult form of hypophosphatasia are reviewed.
RESULTS: Physical examination of our patient was revealing only for short stature. Bone mineral density evaluated by dual-energy x-ray absorptiometry was unremarkable. Biochemical investigations showed normal calcium, elevated inorganic phosphate, and low ALP levels in serum. In light of the hypophosphatasemia and pathologic fracture, the serum pyridoxal 5'-phosphate concentration was measured and found to be considerably elevated, a substantiation of the diagnosis of hypophosphatasia. Analysis of the gene encoding the "tissue-nonspecific" isoenzyme of ALP (TNSALP) demonstrated a novel, heterozygous, missense mutation causing her disorder.
CONCLUSION: Hypophosphatasia is a rare inborn error of metabolism due to a deactivating mutation (or mutations) of the gene encoding TNSALP, in turn leading to global deficiency of TNSALP activity and inadequate skeletal mineralization and fractures. Our patient illustrates the importance of low serum ALP activity in the assessment of patients with fractures. No established treatment exists for hypophosphatasia, but the correct diagnosis should help to avoid the use of traditional therapies for osteoporosis or osteomalacia, which would be ineffective or potentially harmful.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17229666     DOI: 10.4158/EP.12.6.676

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  17 in total

Review 1.  Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.

Authors:  Michael P Whyte
Journal:  Nat Rev Endocrinol       Date:  2016-02-19       Impact factor: 43.330

2.  Clinical, radiographic and biochemical characteristics of adult hypophosphatasia.

Authors:  T Schmidt; H Mussawy; T Rolvien; T Hawellek; J Hubert; W Rüther; M Amling; F Barvencik
Journal:  Osteoporos Int       Date:  2017-05-25       Impact factor: 4.507

Review 3.  Proposing a clinical algorithm for better diagnosis of hypophosphatasia in resource-limiting situations.

Authors:  Sreyanko Sadhukhan; Poonam Mehta; Singh Rajender; Sushil Kumar Gupta; Naibedya Chattopadhyay
Journal:  Osteoporos Int       Date:  2022-07-01       Impact factor: 4.507

4.  Hypophosphatasia may lead to bone fragility: don't miss it.

Authors:  Pierre Moulin; Frédéric Vaysse; Eric Bieth; Etienne Mornet; Isabelle Gennero; Sara Dalicieux-Laurencin; Christiane Baunin; Marie Thérèse Tauber; Jérôme Sales De Gauzy; Jean Pierre Salles
Journal:  Eur J Pediatr       Date:  2008-09-26       Impact factor: 3.183

5.  Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all.

Authors:  F Genest; L Seefried
Journal:  Osteoporos Int       Date:  2018-05-17       Impact factor: 4.507

Review 6.  Hypophosphatasia: an overview of the disease and its treatment.

Authors:  M L Bianchi
Journal:  Osteoporos Int       Date:  2015-08-06       Impact factor: 4.507

7.  Diagnosis of Hypophosphatasia in Adults Presenting With Metatarsal Stress Fracture: Proof-of-Concept for a Case-Finding Strategy.

Authors:  Kenna Koehler; Said Atway; James Pipes; Steven Ing
Journal:  JBMR Plus       Date:  2021-04-02

8.  Adult hypophosphatasia manifests in a marathon runner.

Authors:  Nada Fanous; Diana Barb
Journal:  BMJ Case Rep       Date:  2020-09-09

Review 9.  Childhood hypophosphatasia: to treat or not to treat.

Authors:  Eric T Rush
Journal:  Orphanet J Rare Dis       Date:  2018-07-16       Impact factor: 4.123

10.  Genetic engineering a large animal model of human hypophosphatasia in sheep.

Authors:  Diarra K Williams; Carlos Pinzón; Shannon Huggins; Jane H Pryor; Alyssa Falck; Forrest Herman; James Oldeschulte; Michael B Chavez; Brian L Foster; Sarah H White; Mark E Westhusin; Larry J Suva; Charles R Long; Dana Gaddy
Journal:  Sci Rep       Date:  2018-11-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.